Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRP-108 vs Flutide in adult asthma (Phase 3, single-blind, active-controlled)
jRCT2080221303Phase 3
- Sponsor
- Kyorin Pharmaceutical
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of evogrel in asthma (2 arms), sponsored by Kyorin Pharmaceutical.
02
Drugs
evogrel
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080221303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221303.